nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—CYP3A4—type 2 diabetes mellitus	0.257	1	CbGaD
Lomitapide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.057	0.133	CbGbCtD
Lomitapide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0508	0.118	CbGbCtD
Lomitapide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0367	0.0854	CbGbCtD
Lomitapide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0342	0.0794	CbGbCtD
Lomitapide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0305	0.0708	CbGbCtD
Lomitapide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0279	0.0648	CbGbCtD
Lomitapide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0252	0.0587	CbGbCtD
Lomitapide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0243	0.0566	CbGbCtD
Lomitapide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.022	0.0512	CbGbCtD
Lomitapide—ABCB1—Glyburide—type 2 diabetes mellitus	0.0188	0.0437	CbGbCtD
Lomitapide—ABCB1—Losartan—type 2 diabetes mellitus	0.0172	0.04	CbGbCtD
Lomitapide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0167	0.0388	CbGbCtD
Lomitapide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.016	0.0372	CbGbCtD
Lomitapide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.016	0.0372	CbGbCtD
Lomitapide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0151	0.0352	CbGbCtD
Lomitapide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0113	0.0262	CbGbCtD
Lomitapide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0103	0.024	CbGbCtD
Lomitapide—MTTP—nephron tubule—type 2 diabetes mellitus	0.00333	0.197	CbGeAlD
Lomitapide—MTTP—cardiovascular system—type 2 diabetes mellitus	0.00299	0.177	CbGeAlD
Lomitapide—MTTP—kidney—type 2 diabetes mellitus	0.00292	0.173	CbGeAlD
Lomitapide—MTTP—cortex of kidney—type 2 diabetes mellitus	0.00285	0.168	CbGeAlD
Lomitapide—MTTP—liver—type 2 diabetes mellitus	0.00185	0.109	CbGeAlD
Lomitapide—Antrafenine—PTGS2—type 2 diabetes mellitus	0.000753	0.513	CrCbGaD
Lomitapide—Conivaptan—CYP3A4—type 2 diabetes mellitus	0.000715	0.487	CrCbGaD
Lomitapide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000365	0.0216	CbGeAlD
Lomitapide—CYP3A4—kidney—type 2 diabetes mellitus	0.000365	0.0215	CbGeAlD
Lomitapide—ABCB1—retina—type 2 diabetes mellitus	0.000312	0.0184	CbGeAlD
Lomitapide—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000294	0.0174	CbGeAlD
Lomitapide—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000264	0.0156	CbGeAlD
Lomitapide—ABCB1—kidney—type 2 diabetes mellitus	0.000258	0.0153	CbGeAlD
Lomitapide—ABCB1—pancreas—type 2 diabetes mellitus	0.000256	0.0151	CbGeAlD
Lomitapide—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000251	0.0149	CbGeAlD
Lomitapide—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000233	0.0137	CbGeAlD
Lomitapide—CYP3A4—liver—type 2 diabetes mellitus	0.00023	0.0136	CbGeAlD
Lomitapide—ABCB1—liver—type 2 diabetes mellitus	0.000163	0.00964	CbGeAlD
Lomitapide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000157	0.00082	CcSEcCtD
Lomitapide—Chills—Irbesartan—type 2 diabetes mellitus	0.000157	0.000819	CcSEcCtD
Lomitapide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000818	CcSEcCtD
Lomitapide—Palpitations—Valsartan—type 2 diabetes mellitus	0.000156	0.000817	CcSEcCtD
Lomitapide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000156	0.000816	CcSEcCtD
Lomitapide—Infection—Gliclazide—type 2 diabetes mellitus	0.000156	0.000815	CcSEcCtD
Lomitapide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000155	0.000813	CcSEcCtD
Lomitapide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000155	0.000809	CcSEcCtD
Lomitapide—Palpitations—Orlistat—type 2 diabetes mellitus	0.000154	0.000807	CcSEcCtD
Lomitapide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000154	0.000806	CcSEcCtD
Lomitapide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000154	0.000805	CcSEcCtD
Lomitapide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000154	0.000805	CcSEcCtD
Lomitapide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000153	0.000797	CcSEcCtD
Lomitapide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000152	0.000795	CcSEcCtD
Lomitapide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000152	0.000795	CcSEcCtD
Lomitapide—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000152	0.000794	CcSEcCtD
Lomitapide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000152	0.000794	CcSEcCtD
Lomitapide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000152	0.000793	CcSEcCtD
Lomitapide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00079	CcSEcCtD
Lomitapide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00079	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000151	0.000789	CcSEcCtD
Lomitapide—Myalgia—Valsartan—type 2 diabetes mellitus	0.00015	0.000787	CcSEcCtD
Lomitapide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00015	0.000787	CcSEcCtD
Lomitapide—Chest pain—Valsartan—type 2 diabetes mellitus	0.00015	0.000787	CcSEcCtD
Lomitapide—Dizziness—Glipizide—type 2 diabetes mellitus	0.00015	0.000785	CcSEcCtD
Lomitapide—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00015	0.000782	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000149	0.000781	CcSEcCtD
Lomitapide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000149	0.000781	CcSEcCtD
Lomitapide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000149	0.000779	CcSEcCtD
Lomitapide—Myalgia—Orlistat—type 2 diabetes mellitus	0.000149	0.000777	CcSEcCtD
Lomitapide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000149	0.000777	CcSEcCtD
Lomitapide—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000148	0.000776	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000148	0.000772	CcSEcCtD
Lomitapide—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000147	0.000769	CcSEcCtD
Lomitapide—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000147	0.000769	CcSEcCtD
Lomitapide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000147	0.000768	CcSEcCtD
Lomitapide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000146	0.000763	CcSEcCtD
Lomitapide—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000145	0.00076	CcSEcCtD
Lomitapide—Malaise—Metformin—type 2 diabetes mellitus	0.000145	0.000759	CcSEcCtD
Lomitapide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000145	0.000758	CcSEcCtD
Lomitapide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000145	0.000756	CcSEcCtD
Lomitapide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000144	0.000755	CcSEcCtD
Lomitapide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000144	0.000753	CcSEcCtD
Lomitapide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000144	0.000752	CcSEcCtD
Lomitapide—Infection—Valsartan—type 2 diabetes mellitus	0.000143	0.000749	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000143	0.000748	CcSEcCtD
Lomitapide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000143	0.000747	CcSEcCtD
Lomitapide—Headache—Glipizide—type 2 diabetes mellitus	0.000142	0.000744	CcSEcCtD
Lomitapide—Palpitations—Metformin—type 2 diabetes mellitus	0.000142	0.000744	CcSEcCtD
Lomitapide—Infection—Orlistat—type 2 diabetes mellitus	0.000142	0.00074	CcSEcCtD
Lomitapide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000141	0.00074	CcSEcCtD
Lomitapide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000141	0.000737	CcSEcCtD
Lomitapide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000141	0.000737	CcSEcCtD
Lomitapide—Flatulence—Losartan—type 2 diabetes mellitus	0.000141	0.000736	CcSEcCtD
Lomitapide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000734	CcSEcCtD
Lomitapide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00014	0.000733	CcSEcCtD
Lomitapide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00014	0.000733	CcSEcCtD
Lomitapide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00014	0.000731	CcSEcCtD
Lomitapide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00014	0.000731	CcSEcCtD
Lomitapide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00014	0.00073	CcSEcCtD
Lomitapide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000138	0.000724	CcSEcCtD
Lomitapide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.000723	CcSEcCtD
Lomitapide—Back pain—Losartan—type 2 diabetes mellitus	0.000138	0.000723	CcSEcCtD
Lomitapide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000138	0.000723	CcSEcCtD
Lomitapide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000138	0.000723	CcSEcCtD
Lomitapide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000138	0.00072	CcSEcCtD
Lomitapide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000137	0.000718	CcSEcCtD
Lomitapide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000717	CcSEcCtD
Lomitapide—Chest pain—Metformin—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Lomitapide—Myalgia—Metformin—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Lomitapide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Lomitapide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000136	0.000713	CcSEcCtD
Lomitapide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000136	0.000713	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000136	0.000711	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000136	0.000709	CcSEcCtD
Lomitapide—Discomfort—Metformin—type 2 diabetes mellitus	0.000135	0.000708	CcSEcCtD
Lomitapide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000135	0.000708	CcSEcCtD
Lomitapide—Nausea—Glipizide—type 2 diabetes mellitus	0.000135	0.000706	CcSEcCtD
Lomitapide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000135	0.000705	CcSEcCtD
Lomitapide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000134	0.000703	CcSEcCtD
Lomitapide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000134	0.000702	CcSEcCtD
Lomitapide—Headache—Glimepiride—type 2 diabetes mellitus	0.000133	0.000694	CcSEcCtD
Lomitapide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000133	0.000693	CcSEcCtD
Lomitapide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000692	CcSEcCtD
Lomitapide—Anaemia—Losartan—type 2 diabetes mellitus	0.000132	0.000691	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000131	0.000687	CcSEcCtD
Lomitapide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000684	CcSEcCtD
Lomitapide—Infection—Metformin—type 2 diabetes mellitus	0.000131	0.000682	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00013	0.000679	CcSEcCtD
Lomitapide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00013	0.000677	CcSEcCtD
Lomitapide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000129	0.000676	CcSEcCtD
Lomitapide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000676	CcSEcCtD
Lomitapide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000129	0.000676	CcSEcCtD
Lomitapide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000676	CcSEcCtD
Lomitapide—Malaise—Losartan—type 2 diabetes mellitus	0.000129	0.000674	CcSEcCtD
Lomitapide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000129	0.000673	CcSEcCtD
Lomitapide—Vertigo—Losartan—type 2 diabetes mellitus	0.000128	0.000671	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000128	0.000671	CcSEcCtD
Lomitapide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.000671	CcSEcCtD
Lomitapide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000128	0.00067	CcSEcCtD
Lomitapide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000128	0.000669	CcSEcCtD
Lomitapide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000128	0.000668	CcSEcCtD
Lomitapide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000128	0.000667	CcSEcCtD
Lomitapide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000127	0.000664	CcSEcCtD
Lomitapide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000127	0.000664	CcSEcCtD
Lomitapide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000663	CcSEcCtD
Lomitapide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000661	CcSEcCtD
Lomitapide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000126	0.000661	CcSEcCtD
Lomitapide—Palpitations—Losartan—type 2 diabetes mellitus	0.000126	0.00066	CcSEcCtD
Lomitapide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000126	0.000658	CcSEcCtD
Lomitapide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000656	CcSEcCtD
Lomitapide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000125	0.000656	CcSEcCtD
Lomitapide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000125	0.000656	CcSEcCtD
Lomitapide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000125	0.000656	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.000651	CcSEcCtD
Lomitapide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000124	0.00065	CcSEcCtD
Lomitapide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000124	0.000649	CcSEcCtD
Lomitapide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000649	CcSEcCtD
Lomitapide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Lomitapide—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.000645	CcSEcCtD
Lomitapide—Infection—Irbesartan—type 2 diabetes mellitus	0.000123	0.000644	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000123	0.000643	CcSEcCtD
Lomitapide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000123	0.000642	CcSEcCtD
Lomitapide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000123	0.000641	CcSEcCtD
Lomitapide—Chest pain—Losartan—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Lomitapide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Lomitapide—Myalgia—Losartan—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Lomitapide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Lomitapide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.000636	CcSEcCtD
Lomitapide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00012	0.00063	CcSEcCtD
Lomitapide—Discomfort—Losartan—type 2 diabetes mellitus	0.00012	0.000629	CcSEcCtD
Lomitapide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00012	0.000627	CcSEcCtD
Lomitapide—Headache—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Lomitapide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00012	0.000625	CcSEcCtD
Lomitapide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000119	0.000622	CcSEcCtD
Lomitapide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.000617	CcSEcCtD
Lomitapide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000118	0.000617	CcSEcCtD
Lomitapide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000118	0.000616	CcSEcCtD
Lomitapide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000117	0.000614	CcSEcCtD
Lomitapide—Somnolence—Metformin—type 2 diabetes mellitus	0.000117	0.000611	CcSEcCtD
Lomitapide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000609	CcSEcCtD
Lomitapide—Infection—Losartan—type 2 diabetes mellitus	0.000116	0.000606	CcSEcCtD
Lomitapide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000116	0.000605	CcSEcCtD
Lomitapide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000114	0.000598	CcSEcCtD
Lomitapide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000114	0.000597	CcSEcCtD
Lomitapide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000596	CcSEcCtD
Lomitapide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000114	0.000595	CcSEcCtD
Lomitapide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000594	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000113	0.000593	CcSEcCtD
Lomitapide—Fatigue—Metformin—type 2 diabetes mellitus	0.000113	0.000592	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000113	0.00059	CcSEcCtD
Lomitapide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000113	0.00059	CcSEcCtD
Lomitapide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Lomitapide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Lomitapide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Lomitapide—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.000587	CcSEcCtD
Lomitapide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000582	CcSEcCtD
Lomitapide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.000581	CcSEcCtD
Lomitapide—Malaise—Ramipril—type 2 diabetes mellitus	0.000111	0.000578	CcSEcCtD
Lomitapide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00011	0.000576	CcSEcCtD
Lomitapide—Vertigo—Ramipril—type 2 diabetes mellitus	0.00011	0.000576	CcSEcCtD
Lomitapide—Headache—Glyburide—type 2 diabetes mellitus	0.00011	0.000573	CcSEcCtD
Lomitapide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.00057	CcSEcCtD
Lomitapide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000108	0.000566	CcSEcCtD
Lomitapide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000108	0.000566	CcSEcCtD
Lomitapide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000108	0.000563	CcSEcCtD
Lomitapide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000562	CcSEcCtD
Lomitapide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000562	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.00056	CcSEcCtD
Lomitapide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000107	0.000559	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000106	0.000556	CcSEcCtD
Lomitapide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.000554	CcSEcCtD
Lomitapide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000105	0.000548	CcSEcCtD
Lomitapide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000546	CcSEcCtD
Lomitapide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000104	0.000546	CcSEcCtD
Lomitapide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000546	CcSEcCtD
Lomitapide—Nausea—Glyburide—type 2 diabetes mellitus	0.000104	0.000543	CcSEcCtD
Lomitapide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000543	CcSEcCtD
Lomitapide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000104	0.000543	CcSEcCtD
Lomitapide—Somnolence—Losartan—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Lomitapide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000103	0.000541	CcSEcCtD
Lomitapide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.000539	CcSEcCtD
Lomitapide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000103	0.000537	CcSEcCtD
Lomitapide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000102	0.000535	CcSEcCtD
Lomitapide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.000534	CcSEcCtD
Lomitapide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000102	0.000534	CcSEcCtD
Lomitapide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000101	0.00053	CcSEcCtD
Lomitapide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.00053	CcSEcCtD
Lomitapide—Fatigue—Losartan—type 2 diabetes mellitus	0.000101	0.000526	CcSEcCtD
Lomitapide—Vomiting—Gliclazide—type 2 diabetes mellitus	9.98e-05	0.000522	CcSEcCtD
Lomitapide—Constipation—Losartan—type 2 diabetes mellitus	9.98e-05	0.000522	CcSEcCtD
Lomitapide—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000516	CcSEcCtD
Lomitapide—Headache—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000514	CcSEcCtD
Lomitapide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000513	CcSEcCtD
Lomitapide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000512	CcSEcCtD
Lomitapide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000512	CcSEcCtD
Lomitapide—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.75e-05	0.00051	CcSEcCtD
Lomitapide—Skin disorder—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000508	CcSEcCtD
Lomitapide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000506	CcSEcCtD
Lomitapide—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.61e-05	0.000503	CcSEcCtD
Lomitapide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.54e-05	0.000499	CcSEcCtD
Lomitapide—Dizziness—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000499	CcSEcCtD
Lomitapide—Dizziness—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000493	CcSEcCtD
Lomitapide—Asthenia—Metformin—type 2 diabetes mellitus	9.43e-05	0.000493	CcSEcCtD
Lomitapide—Nausea—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000488	CcSEcCtD
Lomitapide—Body temperature increased—Losartan—type 2 diabetes mellitus	9.22e-05	0.000482	CcSEcCtD
Lomitapide—Abdominal pain—Losartan—type 2 diabetes mellitus	9.22e-05	0.000482	CcSEcCtD
Lomitapide—Vomiting—Valsartan—type 2 diabetes mellitus	9.17e-05	0.000479	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000476	CcSEcCtD
Lomitapide—Vomiting—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000474	CcSEcCtD
Lomitapide—Headache—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000472	CcSEcCtD
Lomitapide—Diarrhoea—Metformin—type 2 diabetes mellitus	8.99e-05	0.00047	CcSEcCtD
Lomitapide—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.98e-05	0.00047	CcSEcCtD
Lomitapide—Headache—Orlistat—type 2 diabetes mellitus	8.93e-05	0.000467	CcSEcCtD
Lomitapide—Asthenia—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000465	CcSEcCtD
Lomitapide—Somnolence—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000465	CcSEcCtD
Lomitapide—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.81e-05	0.00046	CcSEcCtD
Lomitapide—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000455	CcSEcCtD
Lomitapide—Dizziness—Metformin—type 2 diabetes mellitus	8.69e-05	0.000454	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000452	CcSEcCtD
Lomitapide—Fatigue—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000451	CcSEcCtD
Lomitapide—Nausea—Valsartan—type 2 diabetes mellitus	8.57e-05	0.000448	CcSEcCtD
Lomitapide—Constipation—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000447	CcSEcCtD
Lomitapide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000443	CcSEcCtD
Lomitapide—Nausea—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000443	CcSEcCtD
Lomitapide—Asthenia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000438	CcSEcCtD
Lomitapide—Vomiting—Metformin—type 2 diabetes mellitus	8.35e-05	0.000437	CcSEcCtD
Lomitapide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000431	CcSEcCtD
Lomitapide—Headache—Metformin—type 2 diabetes mellitus	8.23e-05	0.00043	CcSEcCtD
Lomitapide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000429	CcSEcCtD
Lomitapide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000428	CcSEcCtD
Lomitapide—Diarrhoea—Losartan—type 2 diabetes mellitus	7.98e-05	0.000417	CcSEcCtD
Lomitapide—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000413	CcSEcCtD
Lomitapide—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000413	CcSEcCtD
Lomitapide—Vomiting—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000412	CcSEcCtD
Lomitapide—Nausea—Metformin—type 2 diabetes mellitus	7.8e-05	0.000408	CcSEcCtD
Lomitapide—Headache—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000406	CcSEcCtD
Lomitapide—Dizziness—Losartan—type 2 diabetes mellitus	7.71e-05	0.000403	CcSEcCtD
Lomitapide—Vomiting—Losartan—type 2 diabetes mellitus	7.42e-05	0.000388	CcSEcCtD
Lomitapide—Nausea—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000385	CcSEcCtD
Lomitapide—Headache—Losartan—type 2 diabetes mellitus	7.31e-05	0.000382	CcSEcCtD
Lomitapide—Asthenia—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000375	CcSEcCtD
Lomitapide—Nausea—Losartan—type 2 diabetes mellitus	6.93e-05	0.000362	CcSEcCtD
Lomitapide—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000358	CcSEcCtD
Lomitapide—Dizziness—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000346	CcSEcCtD
Lomitapide—Vomiting—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000333	CcSEcCtD
Lomitapide—Headache—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000328	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTM1—type 2 diabetes mellitus	6.2e-05	0.000604	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LPL—type 2 diabetes mellitus	6.09e-05	0.000593	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	6.07e-05	0.000591	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	6.02e-05	0.000586	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	6.01e-05	0.000584	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ADCY5—type 2 diabetes mellitus	5.96e-05	0.00058	CbGpPWpGaD
Lomitapide—Nausea—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000311	CcSEcCtD
Lomitapide—MTTP—Metabolism—GPX1—type 2 diabetes mellitus	5.94e-05	0.000578	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	5.84e-05	0.000568	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CD36—type 2 diabetes mellitus	5.79e-05	0.000563	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPP2CA—type 2 diabetes mellitus	5.71e-05	0.000556	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	5.51e-05	0.000536	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MTHFR—type 2 diabetes mellitus	5.48e-05	0.000533	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARA—type 2 diabetes mellitus	5.38e-05	0.000523	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AGT—type 2 diabetes mellitus	5.21e-05	0.000507	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CALM1—type 2 diabetes mellitus	5.12e-05	0.000498	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	5.12e-05	0.000498	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—type 2 diabetes mellitus	5.1e-05	0.000497	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOA1—type 2 diabetes mellitus	5.05e-05	0.000491	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	4.76e-05	0.000463	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.72e-05	0.000459	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.55e-05	0.000443	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.55e-05	0.000443	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—type 2 diabetes mellitus	4.45e-05	0.000433	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—INS—type 2 diabetes mellitus	4.36e-05	0.000424	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	4.18e-05	0.000406	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.17e-05	0.000405	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.04e-05	0.000393	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—type 2 diabetes mellitus	4e-05	0.000389	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.91e-05	0.00038	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	3.87e-05	0.000377	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.86e-05	0.000375	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	3.85e-05	0.000374	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3R1—type 2 diabetes mellitus	3.82e-05	0.000372	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NOS3—type 2 diabetes mellitus	3.82e-05	0.000372	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	3.81e-05	0.00037	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	3.79e-05	0.000369	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.71e-05	0.000361	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.71e-05	0.000361	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.57e-05	0.000348	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.57e-05	0.000348	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.51e-05	0.000342	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—type 2 diabetes mellitus	3.5e-05	0.00034	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	3.28e-05	0.00032	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	3.27e-05	0.000318	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.24e-05	0.000316	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.23e-05	0.000314	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.19e-05	0.00031	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.18e-05	0.00031	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.15e-05	0.000306	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.04e-05	0.000296	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	3.03e-05	0.000295	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	3.01e-05	0.000293	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.93e-05	0.000285	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	2.82e-05	0.000274	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.81e-05	0.000274	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.65e-05	0.000257	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.65e-05	0.000257	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.52e-05	0.000246	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.51e-05	0.000244	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.51e-05	0.000244	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.48e-05	0.000241	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.45e-05	0.000238	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.44e-05	0.000238	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.42e-05	0.000235	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.41e-05	0.000235	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.39e-05	0.000233	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.33e-05	0.000227	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.33e-05	0.000227	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.28e-05	0.000221	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.26e-05	0.00022	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.25e-05	0.000219	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.21e-05	0.000215	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.21e-05	0.000215	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.17e-05	0.000211	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.13e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.13e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.13e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.13e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.13e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.07e-05	0.000201	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.06e-05	0.0002	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.98e-05	0.000193	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.95e-05	0.00019	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.95e-05	0.00019	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.91e-05	0.000186	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.9e-05	0.000185	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.89e-05	0.000184	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.87e-05	0.000181	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.81e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.81e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.81e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.81e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.79e-05	0.000174	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—type 2 diabetes mellitus	1.76e-05	0.000171	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.74e-05	0.000169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.74e-05	0.000169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.67e-05	0.000163	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.67e-05	0.000163	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.66e-05	0.000162	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.64e-05	0.00016	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.63e-05	0.000159	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.63e-05	0.000159	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.62e-05	0.000158	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.62e-05	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.62e-05	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.62e-05	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.56e-05	0.000152	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.56e-05	0.000151	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.55e-05	0.00015	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.55e-05	0.00015	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.54e-05	0.00015	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.52e-05	0.000148	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.49e-05	0.000145	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.49e-05	0.000145	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.47e-05	0.000143	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.46e-05	0.000142	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.42e-05	0.000138	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.39e-05	0.000135	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.39e-05	0.000135	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.37e-05	0.000134	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.37e-05	0.000134	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.37e-05	0.000134	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.37e-05	0.000134	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.36e-05	0.000132	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.36e-05	0.000132	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.32e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.31e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.31e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.31e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.31e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.31e-05	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.27e-05	0.000124	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.26e-05	0.000122	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.23e-05	0.000119	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.2e-05	0.000117	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.2e-05	0.000117	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.18e-05	0.000115	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.17e-05	0.000114	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.14e-05	0.000111	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.07e-05	0.000104	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.07e-05	0.000104	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.07e-05	0.000104	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.05e-05	0.000102	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.03e-05	0.000101	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.03e-05	0.0001	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.03e-05	0.0001	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.01e-05	9.86e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.96e-06	9.69e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.96e-06	9.69e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.96e-06	9.69e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.79e-06	9.53e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.79e-06	9.53e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.79e-06	9.53e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.61e-06	9.35e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.53e-06	9.27e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.36e-06	9.11e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.34e-06	9.09e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.32e-06	9.07e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.96e-06	8.71e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.86e-06	8.62e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.86e-06	8.62e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.77e-06	8.53e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.64e-06	8.4e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.49e-06	8.26e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.49e-06	8.26e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.47e-06	8.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.47e-06	8.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.47e-06	8.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.47e-06	8.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.12e-06	7.9e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.55e-06	7.34e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.32e-06	7.12e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.32e-06	7.12e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.29e-06	7.09e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.19e-06	6.99e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.05e-06	6.86e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.98e-06	6.79e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.9e-06	6.72e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.9e-06	6.72e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.79e-06	6.6e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.77e-06	6.59e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.73e-06	6.54e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.73e-06	6.54e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.73e-06	6.54e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.69e-06	6.5e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.66e-06	6.48e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.57e-06	6.39e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.52e-06	6.35e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.5e-06	6.32e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.49e-06	6.31e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.33e-06	6.16e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.25e-06	6.08e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.03e-06	5.87e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.03e-06	5.87e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.03e-06	5.87e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6e-06	5.84e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.92e-06	5.76e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.89e-06	5.73e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.87e-06	5.71e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.74e-06	5.59e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.7e-06	5.55e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.6e-06	5.45e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.59e-06	5.43e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.52e-06	5.37e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.52e-06	5.37e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.46e-06	5.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.46e-06	5.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.23e-06	5.09e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.23e-06	5.09e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.86e-06	4.73e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.77e-06	4.64e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.51e-06	4.39e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.51e-06	4.39e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.49e-06	4.37e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.43e-06	4.31e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.37e-06	4.26e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.3e-06	4.18e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.18e-06	4.07e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.18e-06	4.07e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.18e-06	4.07e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.11e-06	3.99e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.02e-06	3.91e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.01e-06	3.9e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.9e-06	3.79e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.85e-06	3.75e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.83e-06	3.72e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.7e-06	3.6e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.63e-06	3.53e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.51e-06	3.42e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.45e-06	3.36e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.44e-06	3.35e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.4e-06	3.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3e-06	2.92e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.94e-06	2.86e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.7e-06	2.62e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	2.51e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	2.51e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	2.29e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	1.87e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.15e-05	CbGpPWpGaD
